ANGIOVIST 282: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include administration: INTRAVENOUS, special_features: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT, features_provided: STERILE, primary_container_type: VIAL, therapeutic_equivalent: RATED AP, pharmaceutical_vehicle_type: AQUEOUS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-180-6913, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| features_provided | STERILE |
| primary_container_type | VIAL |
| therapeutic_equivalent | RATED AP |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 20 |
| primary_container_content_quantity | 100.000 MILLILITERS |
| NSN | 6505-01-180-6913 |
| ADMINISTRATION | INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 150.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | STOPPER SHALL BE COMPATIBLE WITH PIERCING DEVICE OF THE STOCK LISTED INTRAVENOUS INJECTION SETS; WITH HANGERS; ACTIVE MEDICAMENT MEDICINAL STRENGTH: 60.000 PERCENTAGE, W/V MEGLUMINE DIATRIZOATE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |
No substitute or cross-reference records for this part.